Perforin protects against autoimmunity in lupus-prone mice

Journal of Immunology

Volumn 160, Issue 2, 1998, Pages 652-660

  Peng, Stanford L ^a,b   Moslehi, Javid ^a   Robert, Marie E ^a   Craft, Joe ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; PERFORIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOTOXICITY; HISTOPATHOLOGY; HOMEOSTASIS; HYPERGAMMAGLOBULINEMIA; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIGENS, CD95; AUTOIMMUNE DISEASES; CELL MOVEMENT; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; LUPUS NEPHRITIS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; PORE FORMING CYTOTOXIC PROTEINS; SURVIVAL ANALYSIS;

EID: 0031974934     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198.
2. Morse, H. C., III, W. F. Davidson, R. A. Yetter, E. D. Murphy, J. B. Roths, and R. L. Coffman. 1982. Abnormalities induced by the mutant gene lpr: expansion of a unique lymphocyte subset. J. Immunol. 129:2612.
3. Singer, G. G., and A. K. Abbas. 1994. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
4. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
5. Renno, T., M. Hahne, J. Tschopp, and H. R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and up-regulate Fas and Fas ligand. J. Exp. Med. 183:431.
6. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
7. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
8. Adachi, M., F. R. Watanabe, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
9. Chu, J. L., J. Drappa, A. Parnassa, and K. B. Elkon. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178:723.
10. Kobayashi, S., T. Hirano, M. Kakinuma, and T. Uede. 1993. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem. Biophys. Res. Commun. 191:617.
11. Wu, J., T. Zhou, J. He, and J. D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461.
12. Zhou, T., C. K. Edwards III, P. Yang, Z. Wang, H. Bluethmann, and J. D. Mountz. 1996. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 156:2661.
13. Jonsson, R., A. Tarkowski, K. Backman, R. Holmdahl, and L. Klareskog. 1987. Sialadenitis in the MRL-1 mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 60:611.
14. Hewicker, M., and G. Trautwein. 1986. Glomerular lesions in MRL mice: a light and immunofluorescence microscopic study. Zentralbl. Veterinaermed. [B] 33: 727.
15. Vlahakos, D. V., M. H. Foster, S. Adams, M. Katz, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio. 1992. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 41:1690.
16. Vlahakos, D., M. H. Foster, A. A. Ucci, K. J. Barrett, S. K. Datta, and M. P. Madaio. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2:1345.
17. Hewicker, M., E. Kromschröder, and G. Trautwein. 1989. Untersuchungen zur pathogenese der glomerulonephritis be MRL-Mäusen: muriner lupus erythematodes. Verh. Dtsch. Ges. Pathol. 73:129.
18. Hewicker, M., E. Kromschröder, and G. Trautwein. 1990. Detection of circulating immune complexes in MRL mice with different forms of glomerulonephritis. Z. Verstierkd. 33:149.
19. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167:1713.
20. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179:1137.
21. Koh, D.-R., A. Ho, A. Rahemutulla, W.-P. Fung-Leung, H. Griesser, and T.-W. Mak. 1995. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25:2558.
22. Peng, S. L., and J. Craft. 1997. The regulation of murine lupus. Ann. NY Acad. Sci. 815:128.
23. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
24. 1 lupus-like nephritis with monoclonal antibody to γ interferon. J. Exp. Med. 166:798.
25. 1 mice. J. Clin. Invest. 94:585.
26. 1 mice. J. Exp. Med. 179:305.
27. Ozmen, L., D. Roman, M. Fountoulakis, G. Schmid, B. Ryffel, and G. Garotta. 1995. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25:6.
28. Schorlemmer, H. U., G. Dickneite, E. J. Kanzy, and K. H. Enssle. 1995. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Inflamm. Res. 44:S194.
29. Huang, F.-P., G.-J. Feng, G. Lindop, D. I. Stott, and F. Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J. Exp. Med. 183:1447.
30. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936.
31. + T cells. Nature 376:181.
32. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
33. Scott, D. W., T. Grdina, and Y. Shi. 1996. T cells commit suicide, but B cells are murdered! J. Immunol. 156:2352.
34. Peng, S. L., M. P. Madaio, A. C. Hayday, and J. Craft. 1996. Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 157:5689.
35. Peng, S. L., M. P. Madaio, D. P. M. Hughes, I. N. Crispe, M. J. Owen, L. Wen, A. C. Hayday, and J. Craft. 1996. Murine lupus in the absence of αβ T cells. J. Immunol. 156:4041.
36. Peng, S. L., M. E. Robert, A. C. Hayday, and J. Craft. 1996. A tumor suppressor function for fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184:1149.
37. Lee, R. K., J. Spielman, D. Y. Zhao, K. J. Olsen, and E. R. Podack. 1996. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157:1919.
38. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
39. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
40. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370: 650.
41. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
42. Hammond, D. M., P. S. Nagarkatti, L. R. Gote, A. Seth, M. R. Hassuneh, and M. Nagarkatti. 1993. Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perform gene. J. Exp. Med. 178:2225.
43. 1 lupus mice decreases with methylprednisolone treatment. Am. J. Pathol. 139:731.
44. 1 mice with overt autoimmune disease. Autoimmunity 12:117.
45. Hughes, D. P. M., A. Hayday, J. E. Craft, M. J. Owen, and I. N. Crispe. 1995. T cells with the γ/δ T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-α-deficient lpr mice. J. Exp. Med. 182:233.
46. Chadwick, B. S., and R. G. Miller. 1992. Hybrid resistance in vitro: possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J. Immunol. 148:2307.
47. Eisenberg, R. A., S. Y. Craven, C. L. Fisher, S. C. Morris, R. Rapoport, D. S. Pisetsky, and P. L. Cohen. 1989. The genetics of autoantibody production in MRL/lpr lupus mice. Clin. Exp. Rheumatol. 7:S35.
48. Shlomchik, M. J., M. P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180:1295.
49. Perkins, D. L., R. M. Glaser, C. A. Mahon, J. Michaelson, and A. Marshak-Rothstein. 1990. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 145:549.
50. Nemazee, D., C. Guiet, K. Buerki, and A. Marshak-Rothstein. 1991. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras. J. Immunol. 147:2536.
51. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441.
52. Montel, A. H., M. R. Bochan, J. A. Hobbs, D. H. Lynch, and Z. Brahmi. 1995. Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol: 166:236.
53. Yamauchi, A., K. Taga, H. S. Mostowski, and E. T. Bloom. 1996. Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events. Blood 87:5127.
54. Braun, M. Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657.
55. Guinee, D., Jr., E. Jaffe, D. Kingma, N. Fishback, K. Wallberg, J. Krishnan, G. Frizzera, W. Travis, and M. Koss. 1994. Pulmonary lymphomatoid granulomatosis: evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am. J. Surg. Pathol. 18:753.
56. Myers, J. L., P. J. Kurtin, A. L. Katzenstein, H. D. Tazelaar, T. V. Colby, J. G. Strickler, R. V. Lloyd, and P. G. Isaacson. 1995. Lymphomatoid granulomatosis: evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am. J. Surg. Pathol. 19:1300.
57. Wilson, W. H., D. W. Kingma, M. Raffeld, R. E. Wittes, and E. S. Jaffe. 1996. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 87:4531.
58. Herndier, B. G., L. D. Kaplan, and M. S. McGrath. 1994. Pathogenesis of AIDS lymphomas. AIDS 8:1025.
59. Levine, A. M. 1994. AIDS-related malignancies. Curr. Opin. Oncol. 6:489.
60. Fox, D. A., and W. J. McCune. 1994. Immunosuppressive drug therapy of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 20:265.
61. Alarcon-Segovia, D. 1994. The treatment of systemic lupus erythematosus. Clin. Exp. Rheumatol. 12:S49.